Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies
Aaron D. Gingerich, Jarrod J. Mousa
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 22

Showing 22 citing articles:

Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
Miwako Kobayashi, Tamara Pilishvili, Jennifer L. Farrar, et al.
MMWR Recommendations and Reports (2023) Vol. 72, Iss. 3, pp. 1-39
Open Access | Times Cited: 73
PCV13, PCV15 or PCV20: Which vaccine is best for children in terms of immunogenicity?
Philippe De Wals
Canada Communicable Disease Report (2024) Vol. 50, Iss. 1/2, pp. 35-39
Open Access | Times Cited: 8
Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States
Zinan Yi, Kwame Owusu‐Edusei, Elamin H. Elbasha
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 12, pp. 2597-2615
Open Access | Times Cited: 4
Immunochemical Characteristics and Functional Activity of Monoclonal Antibodies Obtained to the Recombinant Form of Pneumolysin
I. V. Yakovleva, Н. Ф. Гаврилова, Е. А. Курбатова, et al.
Bulletin of Experimental Biology and Medicine (2025)
Closed Access
Adenosine 2B Receptor Signaling Impairs Vaccine-Mediated Protection Against Pneumococcal Infection in Young Hosts by Blunting Neutrophil Killing of Antibody-Opsonized Bacteria
Shaunna R. Simmons, Alexsandra P. Lenhard, Michael Battaglia, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 414-414
Open Access
Economic evaluation of PCV21 in vaccine-naïve adults aged 19-64 years with underlying medical conditions in the United States
Zinan Yi, Elamin H. Elbasha, Kwame Owusu‐Edusei
Journal of Medical Economics (2025), pp. 1-14
Open Access
Characterization of the innate immune response to Streptococcus pneumoniae infection in zebrafish
Anni K. Saralahti, Sanna-Kaisa E. Harjula, Tommi Rantapero, et al.
PLoS Genetics (2023) Vol. 19, Iss. 1, pp. e1010586-e1010586
Open Access | Times Cited: 7
Synergistic Protection against Secondary Pneumococcal Infection by Human Monoclonal Antibodies Targeting Distinct Epitopes
Aaron D. Gingerich, Fredejah Royer, Anna L. McCormick, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 1, pp. 50-60
Open Access | Times Cited: 6
Serological Profiling of Pneumococcal Proteins Reveals Unique Patterns of Acquisition, Maintenance, and Waning of Antibodies Throughout Life
Samantha W J He, Franziska Voß, Mioara Alina Nicolaie, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 1
Advances in nucleic acid aptamer-based detection of respiratory virus and bacteria: a mini review
Rui-Min Feng, Ye Liu, Zhiqiang Liu, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-ResistantKlebsiella pneumoniae
Kasturi Banerjee, Michael P. Motley, Camila Boniche-Alfaro, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 6
PCV13, PCV15 ou PCV20 : Quel est le meilleur vaccin pour les enfants en matière d’immunogénicité?
Philippe De Wals
Relevé des maladies transmissibles au Canada (2024) Vol. 50, Iss. 1/2, pp. 40-45
Open Access
Monogenic Inborn Errors of Immunity with impaired IgG response to polysaccharide antigens but normal IgG levels and normal IgG response to protein antigens
Maria Faßhauer, Sarah S. Dinges, Olga Staudacher, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access
Serotype 15c Streptococcus Pneumoniae Resistant to Classical Complement Deposition and Agglutination by Polyclonal Rabbit Anti-Capsular 15b Sera
Yazdani B. Shaik-Dasthagirisaheb, Edward J. Kochis, Nicolas Munarriz, et al.
(2024)
Closed Access
Developing meningococcal and bacterial vaccines using reverse vaccinology Review on the development of the meningococcal and bacterial vaccines (Streptococcus and Staphylococcus) using reverse vaccinology
Silvana Beutinger Marchioro, Alex Torres, Marcos Borges Ribeiro
Elsevier eBooks (2024), pp. 321-343
Closed Access
An Update on Pneumococcal Vaccination
Jun Hyung Lee
Korean Journal of Family Practice (2024) Vol. 14, Iss. 3, pp. 121-125
Closed Access
Serotype 15C Streptococcus pneumoniae resistant to classical complement deposition and agglutination by polyclonal rabbit anti-capsular 15B sera
Edward J. Kochis, Yazdani B. Shaik-Dasthagirisaheb, Nicolas Munarriz, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126419-126419
Closed Access
Interplay between Lung Diseases and Viral Infections: A Comprehensive Review
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Microorganisms (2024) Vol. 12, Iss. 10, pp. 2030-2030
Open Access
Antibody-based therapy: an alternative for antimicrobial treatment in the post-antibiotic era
Liang Luo, Qing Li, Xing Chen, et al.
Microbiological Research (2024) Vol. 290, pp. 127974-127974
Closed Access
Antibacterial Activity of Rainbow Trout Plasma: In Vitro Assays and Proteomic Analysis
T.E. Mizaeva, Kalimat Alieva, E. R. Zulkarneev, et al.
Animals (2023) Vol. 13, Iss. 22, pp. 3565-3565
Open Access | Times Cited: 1
Development of the test system based on enzyme immunoassay for the detection of recombinant <i>Streptococcus</i> pneumoniae pneumolysin
Е. А. Курбатова, I. V. Yakovleva, Н. Ф. Гаврилова, et al.
Russian Journal of Biotherapy (2023) Vol. 22, Iss. 4, pp. 52-59
Open Access | Times Cited: 1
Synergistic protection against secondary pneumococcal infection by human monoclonal antibodies targeting distinct epitopes
Aaron D. Gingerich, Fredejah Royer, Anna L. McCormick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 2
Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage
Barbara Milani, Tanila Wood dos Santos, Maria Eduarda Souza Guerra, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0291203-e0291203
Open Access
Page 1

Scroll to top